IL17A and posterior cortical atrophy: Preliminary conclusions from these analyses of the expression of immunohistochemical (IHC) markers in PCa, such as IL-17A and its receptor IL-17RA, suggest their potential usefulness in the process of improving diagnostics, determining the risk of progression (including metastasis), and response to primary and adjuvant treatment.